Tcg Crossover Management, LLC Adverum Biotechnologies, Inc. Transaction History

Tcg Crossover Management, LLC

  • $668 Million
  • Q2 2024

A detailed history of Tcg Crossover Management, LLC transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 2,008,340 shares of ADVM stock, worth $14.9 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
2,008,340
Previous 2,008,340 -0.0%
Holding current value
$14.9 Million
Previous $28.4 Million 51.48%
% of portfolio
2.06%
Previous 2.99%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.8 - $16.06 $1.61 Million - $32.3 Million
2,008,340 New
2,008,340 $28.4 Million

Others Institutions Holding ADVM

# of Institutions
4
Shares Held
2.53M
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $736M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email